Dr. Yuxiang Wang, MD

Dr. Wang practices at Mayo Clinic Hospital - Phoenix in Phoenix, Arizona, part of Mayo Clinic.

Dr. Wang's NPI, 1710408547, was assigned on July 1, 2017. Dr. Wang graduated from Wayne State University School of Medicine in 2017. Dr. Wang holds Arizona license 60308.

Dr. Wang's primary practice is Mayo Clinic Hospital - Phoenix, at 5777 East Mayo Boulevard, Phoenix, AZ 85054 in Maricopa County. The practice phone is (480) 342-4201.

Dr. Wang's primary practice is Mayo Clinic Hospital - Phoenix in Phoenix, Arizona, part of Mayo Clinic. Dr. Wang is also affiliated with Verde Valley Medical Center. The medical group on file is Mayo Clinic. Dmand AI also links Dr. Wang to 1 more ambulatory surgery center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wang practices, 3 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Wang's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dmand AI has Dr. Wang's licenses on file in 2 states: Arizona and Minnesota.

CMS data shows 14 Medicare services from Dr. Wang across 1 procedure code in 2024, all of them office visits, for 29 Medicare patients. Medicare paid $1,216 for them. Every service was in an office.

CMS counts 29 Medicare patients who saw Dr. Wang in 2024. The largest group is 65 to 74, with 18 patients. 75% of them have high cholesterol, and 69% have high blood pressure. Their average risk score is 1.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Wang's median patient age at 68, with 46% women.

In 2024, Dr. Wang wrote 50 Medicare Part D claims for 21 patients. 86% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $128 in total drug cost. In 2023, CMS named 144 claims across 7 drugs.

Dr. Wang accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Wang as offering telehealth.

Dmand AI links 21 papers to Dr. Wang, published from 2011 to 2025. 2025 was the busiest year, with 6. The most frequent topics are Carcinoma, Non-Small-Cell Lung, ErbB Receptors and Heparin. Dr. Wang has published most often in ACS Nano. Dr. Wang's most frequent co-authors are Reza Arsanjani, MD, Timothy Barry, MD and Christopher P. Appleton, MD.

CMS Open Payments shows 15 general payments to Dr. Wang from 7 drug and device companies from 2019 to 2024. Food and beverage make up the largest share, 78% of the total. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) paid the most, $619.

Dr. Wang graduated from Wayne State University School of Medicine in 2017.